Advertisement

AstraZeneca India Extends Its Cancer Screening Programme For Women In Tamil Nadu

In the state of Tamil Nadu, a series of camps (close to 300) are planned to conduct cancer screening for 9000 beneficiaries and create cancer awareness for 30,000 people from Tirunelveli and surrounding districts

AstraZeneca India Private Limited, the services arm of AstraZeneca, a biopharmaceutical company, today announced the expansion of its flagship CSR initiative- Ganga Godavari Cancer Screening Programme to Tamil Nadu in collaboration with its partner Udhavum Ullangal, a public charitable trust. To flag-off the initiative in the state, first screening camp was organised in Tirunelveli. 

In the state of Tamil Nadu, a series of camps (close to 300) are planned to conduct cancer screening for 9000 beneficiaries and create cancer awareness for 30,000 people from Tirunelveli and surrounding districts. 

“This project initiative is aimed at enabling early detection of oral, breast and cervical cancer especially in women from poor below poverty, under-resourced communities across the country. Alongside, it is focused on creating awareness about cancer at large and its symptoms that could possibly trigger early detection leading to timely treatment,” the company stated in a statement. 

“Ganga Godavari Cancer Screening programme is a mission to bring down the burden of cancer by building large scale awareness and encouraging detection in early stages. If you analyse the cancer burden in the country, you will find that the incidence of cancer amongst women is more than what is in men. This means that somewhere there is a gap in reaching out to women and educating them about the disease and how it can be manged well if caught early. With this initiative, we are working to not just detect but also encourage due medical intervention amongst patients and counselling amongst people at risk”, said Gagandeep Singh, Country President AstraZeneca India. 

The initiative was first launched in the year 2019 and has covered multiple states in its previous phases including Maharashtra, Kerala, Uttar Pradesh etc. Despite multiple lockdowns during COVID-19 in the past two years, the programme has touched more than 6000 women and found about 200 positive suspects who have been referred to the partner hospitals for further tests and treatment. 

“The initiative has seen tremendous acceptance and success in the past 3 years across multiple states and we are glad to bring this to Tamil Nadu with Udhavum Ullangal. With this initiative, we aim to reach low-income communities of the state where access to healthcare is a serious constraint and impacts the quality of life. We are constantly working towards a future where everyone has access to knowledge on disease-prevention, quality healthcare and solutions for treatment,” Siva Padmanabhan, Managing Director, AZIPL. 



Advertisement

Around The World